MainPercentage of after hours Emergency Investigational New Drug (IND) requests that OCTEC addressed within two hoursEmergency INDs, described in 21 CFR 312.36, allow FDA to authorize use of an investigational drug in an emergency situation that does not allow time for submission of an IND in accordance with 21 CFR 312.23 or 312.34. All requests are urgent, so it is imperative that those received after normal business hours are addressed immediately. OCTEC serves as the CDER coordinator to provide immediate responses to after-hours emergency IND requests.Percentcolumn501002010Measure was implemented starting December 2010501002011Measure was implemented starting December 2010FY 2011 Overall: 98%501002012FY 2012 Average: 100%http://www.fda.gov/AboutFDA/Transparency/track/ucm206295.htmFDA-TRACK CDER Center Director Offices DashboardMainEmergency IND requests addressed by OCTEC for CDER-regulated products after business hours including weekends and holidaysEmergency INDs, described in 21 CFR 312.36, allow FDA to authorize use of an investigational drug in an emergency situation that does not allow time for submission of an IND in accordance with 21 CFR 312.23 or 312.34. All requests are urgent, so it is imperative that those received after normal business hours are addressed immediately. OCTEC serves as the CDER coordinator to provide immediate responses to after-hours emergency IND requests.Number030201003020112012